CRL4DCAF2 is Required for Mature T-cell Expansion Via Aurora B-regulated Proteasome Activity

Keqi Fan,Fei Wang,Yiyuan Li,Lu Chen,Zhengjun Gao,Yu Zhang,Jin-yuan Duan,Tao Huang,Jiangyan Zhong,Rong-bei Liu,Xintao Mao,Hengyu Fan,Xing Guo,Jin
DOI: https://doi.org/10.1016/j.jaut.2018.08.006
IF: 14.511
2019-01-01
Journal of Autoimmunity
Abstract:The proliferation of T cells in peripheral lymphoid tissues requires T cell receptor (TCR)-mediated cell cycle entry. However, the underlying mechanism regulating cell cycle progression in mature T cells is incompletely understood. Here, we have identified an E3 ubiquitin ligase, CRL4DCAF2, as a critical mediator controlling M phase exit in activated T cells. DCAF2 expression is induced upon TCR stimulation and its deficiency attenuates T cell expansion. Additionally, DCAF2 T cell-specific knockout mice display impaired peripheral T cell maintenance and reduced severity of various autoimmune diseases. Continuous H4K20me1 modification caused by DCAF2 deficiency inhibits the induction of Aurkb expression, which regulates 26S proteasome activity during G2/M phase. CRL4DCAF2 deficiency causes M phase arrest through proteasome-dependent mechanisms in peripheral T cells. Our findings establish DCAF2 as a novel target for T cell-mediated autoimmunity or inflammatory diseases.
What problem does this paper attempt to address?